Home Shayne Heffernan on InvestmentsEducation T2 Biosystems, Inc. $TTOO in the Buy Zone

Knightsbridge Guide to Trading Stocks like TTOO

Investing in volatile stocks can be a high-risk, high-reward venture, and TTOO (T2 Biosystems, Inc.) is no exception. Volatility, often driven by rapid price fluctuations, can present both opportunities and challenges for traders. Here’s a guide to trading volatile stocks like TTOO:

**1. Understanding Volatility: Volatility refers to the degree of variation in a trading price series over time. Highly volatile stocks like TTOO can experience sharp price movements in short periods, offering traders opportunities for profit but also increasing the risk.

**2. Thorough Research: Before diving into trading, conduct thorough research on the stock. Understand the company’s fundamentals, recent news, financial health, and any upcoming events that might impact its stock price. In the case of TTOO, as a biotechnology company, factors like clinical trial results and FDA approvals can significantly affect its stock.

**3. Risk Management: Develop a solid risk management strategy. Set clear entry and exit points, and decide the maximum amount you are willing to risk on a trade. Given the volatility, consider using stop-loss orders to limit potential losses.

**4. Technical Analysis: Use technical analysis tools to identify trends, support and resistance levels, and key indicators. TTOO’s historical price charts, moving averages, and relative strength index (RSI) can provide insights into potential entry and exit points.

**5. Stay Informed: Volatile stocks are often sensitive to breaking news and events. Stay informed about the latest developments, announcements, and industry trends that could impact TTOO’s stock. Social media, financial news outlets, and company filings are valuable sources of information.

**6. Short-Term Trading Strategies: Consider adopting short-term trading strategies. Day trading or swing

Stochastic Oscillator

One method of interpreting the Stochastic Oscillator is looking for overbought areas (above 80) and oversold areas (below 20). The Stochastic Oscillator is 10.0843. This is an oversold reading. However, a signal is not generated until the Oscillator crosses above 20 The last signal was a buy 7 period(s) ago.

Relative Strength Index (RSI)

The RSI shows overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 32.11. This is not a topping or bottoming area. A buy or sell signal is generated when the RSI moves out of an overbought/oversold area. The last signal was a sell 63 period(s) ago.

Commodity Channel Index (CCI)

The CCI shows overbought (above 100) and oversold (below -100) areas. The current value of the CCI is -123.This is an oversold reading. However, a signal isn’t generated until the indicator crosses above -100. The last signal was a buy 20 period(s) ago.


The Moving Average Convergence/Divergence indicator (MACD) gives signals when it crosses its 9 period signal line. The last signal was a buy 12 period(s) ago.

T2 Biosystems, Inc. is an in-vitro diagnostics company. The Company is focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. The Company is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its primary commercial products include the T2Candida Panel and the T2Bacteria Panel. Its T2Candida Panel is a direct-from-blood test that identifies the lethal form of common bloodstream infections that cause sepsis and candidemia. Its T2Bacteria Panel is a direct-from-blood test that detects certain bacterial pathogens associated with sepsis. Its primary commercial products also include the T2Dx Instrument, the T2Resistance Panel, and the T2SARS-CoV-2 Panel.

Shayne Heffernan

You may also like


Your Trusted Source for Capital Markets & Related News

© 2023 LiveTradingNews.com – For The Traders, By The Traders – All Right Reserved.

The information contained on this website shall not be construed as (i) an offer to purchase or sell, or the solicitation of an offer to purchase or sell, any securities or services, (ii) investment, legal, business or tax advice or an offer to provide such advice, or (iii) a basis for making any investment decision. An offering may only be made upon a qualified investor’s receipt not via this website of formal materials from the Knightsbridge an offering memorandum and subscription documentation (“offering materials”). In the case of any inconsistency between the information on this website and any such offering materials, the offering materials shall control. Securities shall not be offered or sold in any jurisdiction in which such offer or sale would be unlawful unless the requirements of the applicable laws of such jurisdiction have been satisfied. Any decision to invest in securities must be based solely upon the information set forth in the applicable offering materials, which should be read carefully by qualified investors prior to investing. An investment with Knightsbridge is not suitable or desirable for all investors; investors may lose all or a portion of the capital invested. Investors may be required to bear the financial risks of an investment for an indefinite period of time. Qualified investors are urged to consult with their own legal, financial and tax advisors before making any investment. Knightsbridge is a private investment firm that offers investment services to Qualified Investors, Members and Institutions ONLY. Qualified Investors are defined as individuals who have met those Qualifications in the relevant jurisdictions. Members are defined as individuals who have been accepted into the Knightsbridge membership program. Institutions are defined as entities such as banks, pension funds, and hedge funds. If you are not a Qualified Investor, Member or Institution, you are not eligible to invest with Knightsbridge. All investments involve risk, and there is no guarantee of profit. You may lose some or all of your investment. Past performance is not indicative of future results. Knightsbridge is not a registered investment advisor, and this disclaimer should not be construed as investment advice. Please consult with a qualified financial advisor before making any investment decisions. By accessing this website, you agree to the terms of this disclaimer. Thank you for your interest in Knightsbridge.